Chapter/Section Purchase

1 Study Coverage
1.1 Huntington Disease Protein Product Introduction
1.2 Market by Type
1.2.1 Global Huntington Disease Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NI-302
1.2.3 NLF-HD
1.2.4 P-301905
1.2.5 IONIS-HTTRx
1.2.6 Others
1.3 Market by Application
1.3.1 Global Huntington Disease Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Alzheimer's Disease
1.3.3 Kennedy's Disease
1.3.4 Spinocerebellar Ataxia
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Huntington Disease Protein Sales Estimates and Forecasts 2017-2028
2.2 Global Huntington Disease Protein Revenue Estimates and Forecasts 2017-2028
2.3 Global Huntington Disease Protein Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Huntington Disease Protein Sales by Region
2.4.1 Global Huntington Disease Protein Sales by Region (2017-2022)
2.4.2 Global Sales Huntington Disease Protein by Region (2023-2028)
2.5 Global Huntington Disease Protein Revenue by Region
2.5.1 Global Huntington Disease Protein Revenue by Region (2017-2022)
2.5.2 Global Huntington Disease Protein Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Huntington Disease Protein Sales by Manufacturers
3.1.1 Global Top Huntington Disease Protein Manufacturers by Sales (2017-2022)
3.1.2 Global Huntington Disease Protein Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Huntington Disease Protein in 2021
3.2 Global Huntington Disease Protein Revenue by Manufacturers
3.2.1 Global Huntington Disease Protein Revenue by Manufacturers (2017-2022)
3.2.2 Global Huntington Disease Protein Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Huntington Disease Protein Revenue in 2021
3.3 Global Huntington Disease Protein Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Huntington Disease Protein Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Huntington Disease Protein Sales by Type
4.1.1 Global Huntington Disease Protein Historical Sales by Type (2017-2022)
4.1.2 Global Huntington Disease Protein Forecasted Sales by Type (2023-2028)
4.1.3 Global Huntington Disease Protein Sales Market Share by Type (2017-2028)
4.2 Global Huntington Disease Protein Revenue by Type
4.2.1 Global Huntington Disease Protein Historical Revenue by Type (2017-2022)
4.2.2 Global Huntington Disease Protein Forecasted Revenue by Type (2023-2028)
4.2.3 Global Huntington Disease Protein Revenue Market Share by Type (2017-2028)
4.3 Global Huntington Disease Protein Price by Type
4.3.1 Global Huntington Disease Protein Price by Type (2017-2022)
4.3.2 Global Huntington Disease Protein Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Huntington Disease Protein Sales by Application
5.1.1 Global Huntington Disease Protein Historical Sales by Application (2017-2022)
5.1.2 Global Huntington Disease Protein Forecasted Sales by Application (2023-2028)
5.1.3 Global Huntington Disease Protein Sales Market Share by Application (2017-2028)
5.2 Global Huntington Disease Protein Revenue by Application
5.2.1 Global Huntington Disease Protein Historical Revenue by Application (2017-2022)
5.2.2 Global Huntington Disease Protein Forecasted Revenue by Application (2023-2028)
5.2.3 Global Huntington Disease Protein Revenue Market Share by Application (2017-2028)
5.3 Global Huntington Disease Protein Price by Application
5.3.1 Global Huntington Disease Protein Price by Application (2017-2022)
5.3.2 Global Huntington Disease Protein Price Forecast by Application (2023-2028)
6 North America
6.1 North America Huntington Disease Protein Market Size by Type
6.1.1 North America Huntington Disease Protein Sales by Type (2017-2028)
6.1.2 North America Huntington Disease Protein Revenue by Type (2017-2028)
6.2 North America Huntington Disease Protein Market Size by Application
6.2.1 North America Huntington Disease Protein Sales by Application (2017-2028)
6.2.2 North America Huntington Disease Protein Revenue by Application (2017-2028)
6.3 North America Huntington Disease Protein Market Size by Country
6.3.1 North America Huntington Disease Protein Sales by Country (2017-2028)
6.3.2 North America Huntington Disease Protein Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Huntington Disease Protein Market Size by Type
7.1.1 Europe Huntington Disease Protein Sales by Type (2017-2028)
7.1.2 Europe Huntington Disease Protein Revenue by Type (2017-2028)
7.2 Europe Huntington Disease Protein Market Size by Application
7.2.1 Europe Huntington Disease Protein Sales by Application (2017-2028)
7.2.2 Europe Huntington Disease Protein Revenue by Application (2017-2028)
7.3 Europe Huntington Disease Protein Market Size by Country
7.3.1 Europe Huntington Disease Protein Sales by Country (2017-2028)
7.3.2 Europe Huntington Disease Protein Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Huntington Disease Protein Market Size by Type
8.1.1 Asia Pacific Huntington Disease Protein Sales by Type (2017-2028)
8.1.2 Asia Pacific Huntington Disease Protein Revenue by Type (2017-2028)
8.2 Asia Pacific Huntington Disease Protein Market Size by Application
8.2.1 Asia Pacific Huntington Disease Protein Sales by Application (2017-2028)
8.2.2 Asia Pacific Huntington Disease Protein Revenue by Application (2017-2028)
8.3 Asia Pacific Huntington Disease Protein Market Size by Region
8.3.1 Asia Pacific Huntington Disease Protein Sales by Region (2017-2028)
8.3.2 Asia Pacific Huntington Disease Protein Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Huntington Disease Protein Market Size by Type
9.1.1 Latin America Huntington Disease Protein Sales by Type (2017-2028)
9.1.2 Latin America Huntington Disease Protein Revenue by Type (2017-2028)
9.2 Latin America Huntington Disease Protein Market Size by Application
9.2.1 Latin America Huntington Disease Protein Sales by Application (2017-2028)
9.2.2 Latin America Huntington Disease Protein Revenue by Application (2017-2028)
9.3 Latin America Huntington Disease Protein Market Size by Country
9.3.1 Latin America Huntington Disease Protein Sales by Country (2017-2028)
9.3.2 Latin America Huntington Disease Protein Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Huntington Disease Protein Market Size by Type
10.1.1 Middle East and Africa Huntington Disease Protein Sales by Type (2017-2028)
10.1.2 Middle East and Africa Huntington Disease Protein Revenue by Type (2017-2028)
10.2 Middle East and Africa Huntington Disease Protein Market Size by Application
10.2.1 Middle East and Africa Huntington Disease Protein Sales by Application (2017-2028)
10.2.2 Middle East and Africa Huntington Disease Protein Revenue by Application (2017-2028)
10.3 Middle East and Africa Huntington Disease Protein Market Size by Country
10.3.1 Middle East and Africa Huntington Disease Protein Sales by Country (2017-2028)
10.3.2 Middle East and Africa Huntington Disease Protein Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Corporation Information
11.1.2 AFFiRiS AG Overview
11.1.3 AFFiRiS AG Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AFFiRiS AG Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AFFiRiS AG Recent Developments
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Corporation Information
11.2.2 Ionis Pharmaceuticals, Inc. Overview
11.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ionis Pharmaceuticals, Inc. Recent Developments
11.3 Neurimmune Holding AG
11.3.1 Neurimmune Holding AG Corporation Information
11.3.2 Neurimmune Holding AG Overview
11.3.3 Neurimmune Holding AG Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Neurimmune Holding AG Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Neurimmune Holding AG Recent Developments
11.4 nLife Therapeutics, S.L.
11.4.1 nLife Therapeutics, S.L. Corporation Information
11.4.2 nLife Therapeutics, S.L. Overview
11.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 nLife Therapeutics, S.L. Recent Developments
11.5 reMYND NV
11.5.1 reMYND NV Corporation Information
11.5.2 reMYND NV Overview
11.5.3 reMYND NV Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 reMYND NV Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 reMYND NV Recent Developments
11.6 Sangamo BioSciences, Inc.
11.6.1 Sangamo BioSciences, Inc. Corporation Information
11.6.2 Sangamo BioSciences, Inc. Overview
11.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sangamo BioSciences, Inc. Recent Developments
11.7 UniQure N.V.
11.7.1 UniQure N.V. Corporation Information
11.7.2 UniQure N.V. Overview
11.7.3 UniQure N.V. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 UniQure N.V. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 UniQure N.V. Recent Developments
11.8 Voyager Therapeutics, Inc.
11.8.1 Voyager Therapeutics, Inc. Corporation Information
11.8.2 Voyager Therapeutics, Inc. Overview
11.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Voyager Therapeutics, Inc. Recent Developments
11.9 Vybion, Inc.
11.9.1 Vybion, Inc. Corporation Information
11.9.2 Vybion, Inc. Overview
11.9.3 Vybion, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Vybion, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vybion, Inc. Recent Developments
11.10 WAVE Life Sciences Ltd.
11.10.1 WAVE Life Sciences Ltd. Corporation Information
11.10.2 WAVE Life Sciences Ltd. Overview
11.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 WAVE Life Sciences Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Huntington Disease Protein Industry Chain Analysis
12.2 Huntington Disease Protein Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Huntington Disease Protein Production Mode & Process
12.4 Huntington Disease Protein Sales and Marketing
12.4.1 Huntington Disease Protein Sales Channels
12.4.2 Huntington Disease Protein Distributors
12.5 Huntington Disease Protein Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Huntington Disease Protein Industry Trends
13.2 Huntington Disease Protein Market Drivers
13.3 Huntington Disease Protein Market Challenges
13.4 Huntington Disease Protein Market Restraints
14 Key Findings in The Global Huntington Disease Protein Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer